Reversal agents for direct oral anticoagulants for patients experiencing intracerebral haemorrhage

NCS 2024 CME Symposium: Best Practices for DOAC Reversal in Intracranial HemorrhageПодробнее

Anticoagulation, Hemostasis, and Reversal in Neurosurgery by Dr. Christopher LoftusПодробнее

Reversing DOACs: Providing Answers on Why, When, and HowПодробнее

Reversal agents for the management of oral anticoagulant-associated ICHПодробнее

Drug Monitoring and Reversal Agents for Direct Oral AnticoagulantsПодробнее

Intracranial haemorrhage related to direct oral anticoagulant medicationsПодробнее

Overview of Intracerebral Hemorrhage (ICH) — Causes, BP Management, Anticoagulation ReversalПодробнее

How is oral anticoagulant-associated intracerebral hemorrhage currently managed?Подробнее

Reversal Agents for Direct Oral AnticoagulantsПодробнее

Managing Bleeding Events in Patients Receiving Direct Oral AnticoagulantsПодробнее

The Blessing and Curse of Direct Oral Anticoagulants in the Bleeding PatientПодробнее

Reversal of DOACs: Making critical advancementsПодробнее

The value of specific reversal agents in stroke managementПодробнее

DOAC-Related BleedingПодробнее

Reversal of Direct Oral AnticoagulantsПодробнее

Risk factors for oral anticoagulant-associated ICHПодробнее

Patient Pulse: The Patient's Guide to DOAC ReversalПодробнее

Anti-FXa anticoagulation reversal strategies: current evidenceПодробнее

Anticoagulation reversal prior to thrombolysisПодробнее

Direct Oral Anticoagulants: Reversal Strategies for DOACs & Laboratory RoleПодробнее